Ortho Clinical Diagnostics Holdings plc

Ortho Clinical Diagnostics Holdings plc (OCDX) priced its initial public offering on Jan 29, 2021 at $17.00 per share, below its $20.00–$23.00 range, raising $1.29B, and listed on Nasdaq. At the IPO price its market capitalization was about $3.78B. J.P. Morgan was lead-left underwriter, joined by BofA Securities, Goldman Sachs and Barclays and others. Cahill Gordon & Reindel advised the underwriters.

Status

IPO

Ticker

OCDX

Exchange

Nasdaq

Priced

Jan 29, 2021

IPO price

$17.00

Price range

$20.00–$23.00

Raised

$1.29B

Market cap at IPO price

$3.78B

First filed

Jan 4, 2021

Underwriters

J.P. Morgan, BofA Securities, Goldman Sachs, Barclays, Morgan Stanley, Citigroup, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING and Macquarie

Underwriters' counsel

Cahill Gordon & Reindel

Sector

Biotech & pharma

Country / state

NJ

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.